Patrick Barron

Avesthagen Ltd. provides personalized healthcare through convergence of food, pharma and population genetics. It offers genome analysis, transcriptome analysis, metabolome analysis and lead optimization, and recombinant protein expression services, as well as engages in the generation of stable mammalian cell lines over-expressing a recombinant protein, development of product specific bioassays, and design of novel animal component free production media. The company was founded by Villoo Morwala Zareer Patell on April 20, 1998 and is headquartered in Bangalore, India.

AB-Polyblok Ltd. provides drug therapy for the treatment of alzheimer’s disease. It offers revolutionary technology which has the potential to treat and potentially partially reverse, the effects of Alzheimer ’s disease. The company is headquartered in Cambridge, the United Kingdom.

Boundary Capital Partners LLP (Boundary Capital) is a venture capital firm founded in 2009. The firm is headquartered in London.

MATRIX MicroScience was established in August 2000, with a market focus on the development of rapid microbiological tests for the food industry and more recently expanded into the environmental and bio-threat sectors. Current testing methods for the detection of micro-organisms in food are labor intensive and slow, typically taking up to 5 days to obtain a result. For many food types, such as fresh produce and beef, this is of little use. In response to market demand, MATRIX has developed a novel patented system called PATHATRIX. Using RIMS (re-circulating immuno-magnetic separation) technology, PATHATRIX can specifically purify and detect pathogens directly from complex food matrices within hours. For priority cases, the PATHATRIX can be coupled with rapid detection systems to produce a result in as little as 5 hours from point of sample. PATHATRIX employs proven technology at its core that can easily be adopted in any microbiology laboratory, with a minimum of training. Unlike other rapid methods, viable cultures are produced which enable full and detailed analysis of any positive result to be carried out without any further manipulation. PATHATRIX can be used to enhance the performance and reduce the number of 'false positives' of other rapid methods such as PCR, ELISA, chromomeric media etc., and by significantly reducing or eliminating the need for lengthy enrichment and/or selective enrichment steps. The highly innovative Pathatrix Pooling, AOAC-RI approved protocol, provides the customer with dramatic (5x) increase in sample throughput and very significant (>60%) reduction in analysis costs and labor. Sample integrity is maintained 100% enabling the rapid positive identification of individual samples. Linked to rapid methods it provides real-time microbiology for faster product release and incident investigation. Pathatrix has been successfully deployed in real life Salmonella and E.coli O157 outbreaks from contaminated food and has enables food companies and regulatory authorities to rapidly identify the source of contamination.

Moleculight, Inc. operates as a medical imaging company delivering fluorescence image-guidance solutions that provide clinicians with new information about wound bacterial burden for better diagnostic and treatment decisions. Its products include Moleculight i:X and DarkDrape. The company was founded by Ralph S. DaCosta in June 1, 2012 and is headquartered in Toronto, Canada.

Amadeus Capital Partners Ltd is an independent venture capital firm is founded by Anne Glover and Hermann Hauser in 1997. The firm is headquartered in London, UK.

Greer Laboratories, Inc. develops and provides allergy immunotherapy products and services for treating humans and animals. The company was founded in 1904 and is headquartered in Lenoir, NC.

Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom.

Antidote Technologies, Inc. provides online search and referral engine for clinical trials. The firm transforms clinical trials by directly connecting patients with research organizations to make new treatments available. It provides clinical trials information in the areas of Alzheimer's, asthma, bipolar, breast cancer, COPD, depression, diabetes, HIV, leukemia, lung and prostate cancer & rheumatoid arthritis. The company was founded by Jessica Mann, Pablo Graiver and Eithan Ephrati in 2010 and is headquartered in London, the United Kingdom.

Medstrom Ltd. offers specialized hospital equipment and services. It offers total bed management, decontamination services, planned preventative maintenance, audit services, product tracking, and clinical services. The company was founded in 2006 and is headquartered in Derbyshire, the United Kingdom.